![Bethany Sensenig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bethany Sensenig
Directeur/Membre du Conseil chez
SUPERNUS PHARMACEUTICALS, INC.
Fortune : 33 977 $ au 31/05/2026
Profil
Bethany L.
Sensenig is currently an Independent Director at Supernus Pharmaceuticals, Inc. since 2023, KalVista Pharmaceuticals, Inc. starting in 2025, and Alpha Cognition, Inc. starting in 2026.
Also currently serving as Chief Executive & Financial Officer at Naia Rare Diseases LLC.
Former roles include Chief Financial Officer at Radius Health, Inc. from 2023 to 2026, Chief Executive & Financial Officer at 9 Meters Biopharma, Inc. in 2023, Chief Financial Officer & Head-US Operations at Minovia Therapeutics Ltd. from 2019 to 2022, and Vice President-Finance & Commercial Operations at Biogen, Inc. from 2006 to 2019.
Education includes undergraduate studies at Montreat College and an MBA from Western Carolina University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALPHA COGNITION INC 0,03 % | 16/04/2026 | 5 489 ( 0,03 % ) | 33 977 $ | 31/05/2026 |
| 01/10/2025 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 29/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Bethany Sensenig
| Sociétés | Poste | Début |
|---|---|---|
| SUPERNUS PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 21/08/2023 |
| KALVISTA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/10/2025 |
| ALPHA COGNITION INC. | Directeur/Membre du Conseil | 15/04/2026 |
Naia Rare Diseases LLC
 Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Directeur Général | - |
Anciens postes connus de Bethany Sensenig
| Sociétés | Poste | Fin |
|---|---|---|
| RADIUS HEALTH, INC. | Directeur Financier/CFO | 01/04/2026 |
| 9 METERS BIOPHARMA, INC. | Directeur Général | 17/07/2023 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Directeur Financier/CFO | 01/01/2022 |
| BIOGEN INC. | Corporate Officer/Principal | 01/03/2019 |
Formation de Bethany Sensenig
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops and commercializes bone health and related therapeutics | Health Technology |
Montreat College
 Montreat College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Carolina University
 Western Carolina University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Supernus Pharmaceuticals, Inc.
 Supernus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of central nervous system diseases | Health Technology |
KalVista Pharmaceuticals, Inc.
 KalVista Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets small molecule protease inhibitors for diseases | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops mitochondrial cell therapies for clinical-stage biotechnology company | Health Technology |
Naia Rare Diseases LLC
Naia Rare Diseases LLC Medical/Nursing ServicesHealth Services Manufactures biopharmaceutical products | Health Services |
Alpha Cognition, Inc.
 Alpha Cognition, Inc. Financial ConglomeratesFinance Develops pharmaceutical products for treating neurodegenerative diseases | Finance |
